51167-122 : Orkambi Oral Granule


NDC: 51167-122
Labeler: Vertex Pharmaceuticals Incorporated
Product Type: Human Prescription Drug
Drug Name:  Orkambi
Dosage Form: Oral Granule
Application #: NDA211358
Rev. Date: 


NDC Package Codes:

  • 51167-122-01: 56 PACKET IN 1 CARTON (51167‑122‑01) > 1 GRANULE IN 1 PACKET

Active Ingredients:

  • Ivacaftor
  • Lumacaftor

Dosage Strength:

  • 94 mg
  • 75 mg

Pharmaceutical Classes:

  • Chloride Channel Activation Potentiators [MoA]
  • Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]
  • Cytochrome P450 2C8 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • P-Glycoprotein Inducers [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 51167-500 Orkambi Oral Granule by Vertex Pharmaceuticals Incorporated
  • 51167-700 Orkambi Oral Tablet, Film Coated by Vertex Pharmaceuticals Incorporated
  • 51167-809 Orkambi Oral Tablet, Film Coated by Vertex Pharmaceuticals Incorporated
  • 51167-900 Orkambi Oral Granule by Vertex Pharmaceuticals Incorporated

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51167-122 QR Code

< Prev: 51167-113Next: 51167-200 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.